10-Q - Blue Water Acquisition Corp. III (0002050501) (Filer)

SCHEDULE 13G - Blue Water Acquisition Corp. III (0002050501) (Subject)

SCHEDULE 13G - Blue Water Acquisition Corp. III (0002050501) (Subject)

8-K - Blue Water Acquisition Corp. III (0002050501) (Filer)

8-K - Blue Water Acquisition Corp. III (0002050501) (Filer)

SCHEDULE 13G - Blue Water Acquisition Corp. III (0002050501) (Subject)

EFFECT - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

424B3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

S-1 - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

4/A - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

WILMINGTON, Del., Sept. 30, 2025 /PRNewswire/ -- Blue Water Venture Partners, LLC ("Blue Water"), an entity affiliated with Joseph Hernandez, the Chairman and Chief Executive Officer of Blue Water Acquisition Corp III ("BWAC III") announced today that it has formally requested approval from the United States District Court for the District of Delaware to consider its unsolicited $10 billion bid for the assets of CITGO Petroleum Corporation. The motion, filed September 12, 2025, in the matter of Crystallex International Corp. v. Bolivarian Republic of Venezuela (Case No. 17-mc-

In the news release, Blue Water Advances in CITGO Bidding Process, issued 15-Sep-2025 by Blue Water Acquisition Corp iii over PR Newswire, we are advised by the company that the media contact was omitted from the text. The complete, corrected release follows: Blue Water Advances in CITGO Bidding Process NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Blue Water Venture Partners, LLC ("Blue Water"), an entity affiliated with Joeseph Hernandez, the Chairman and Chief Executive Officer of Blue Water Acquisition Corp. III (Nasdaq: "BLUWU"), announced today that it has received court approval to enter into a non-disclosure agreement with the Special Master, granting access to the confidential data ro

NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Blue Water Venture Partners, LLC ("Blue Water"), an entity affiliated with Joeseph Hernandez, the Chairman and Chief Executive Officer of Blue Water Acquisition Corp. III (Nasdaq: "BLUWU"), announced today that it has received court approval to enter into a non-disclosure agreement with the Special Master, granting access to the confidential data room established for the CITGO sale. Blue Water continues to assert that its proposal represents the most compelling and beneficial path forward for all stakeholders. Blue Water's $10 billion b

GREENWICH, Conn., Sept. 5, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (NASDAQ:BLUWU) ("Blue Water" or the "Company") today announced that it has submitted a $10 billion bid to acquire PDV Holding Inc., the parent company of Citgo Petroleum Corp., in a Delaware court-supervised auction process. The Company's proposal would provide cash or stock distributions to PDV Holding Inc.'s general creditors, a $3.2 billion settlement for holders of the PDVSA 2020 bonds to be paid either in cash or in shares of the publicly listed entity that will own Citgo. Citgo Assets Includ

GREENWICH, Conn., July 28, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (NASDAQ:BLUWU) (the "Company") today announced that, commencing July 31, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on The Nasdaq Global Market under the symbols "BLUW" and "BLUWW," respectively

GREENWICH, Conn., June 11, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (the "Company") (NASDAQ:BLUWU), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chairman and Chief Executive Officer Joseph Hernandez, today announced the closing of its upsized initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, at an offering price of $10.00 per unit, resulting in gross proceeds of $253,000,000. The Company'

GREENWICH, Conn., June 10, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chairman and Chief Executive Officer Joseph Hernandez, today announced the upsized pricing of its initial public offering of 22,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. The units are expected to trade on The Nasdaq Global Market ("Nasdaq")under the ticker symbo

GREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ:BLUW), a special purpose acquisition company ("Blue Water"), today announced that its stockholders have voted to approve the proposed business combination (the "Business Combination") with Clarus Therapeutics, Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women ("Clarus") at its special meeting of stockholders (the "Special Meeting") held today, August 27, 2021. Holders of approximately 73.95% of Blue Water's issued and outstanding shares cast votes at the Special Meeting. Approximately 69.57% o

NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUW) ("Blue Water" or the "Company"), a special purpose acquisition company (SPAC) that previously announced a planned business combination with Clarus Therapeutics, Inc. ("Clarus"), announced today that the special meeting of its stockholders (the "Special Meeting") originally scheduled for Thursday, August 12, 2021, is being postponed to Friday, August 27, 2021. As a result of this change, the Special Meeting will now be held at 10:00 a.m., Eastern Time, on August 27, 2021, exclusively via a live audio webcast at https://www.cstproxy.com/bluewateracquisition/2021. Also as a result of this c

New York, NY, April 22, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ:BLUWU) (the "Company") announced today that it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company failed to timely file its Annual Report on Form 10-K for the year ended December 31, 2020 (the "Form 10-K") with the Securities and Exchange Commission ("SEC"). The Notice has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Capital Market. As previously disclosed in the Current Report on Fo

SC 13G/A - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

SC 13G - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

SC 13D - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

SC 13G - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

SC 13G/A - Blue Water Acquisition Corp. (0001817944) (Subject)

SC 13G - Blue Water Acquisition Corp. (0001817944) (Subject)

SC 13G - Blue Water Acquisition Corp. (0001817944) (Subject)